Picture of Sernova logo

SVA Sernova Share Price

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Momentum

Relative Strength (%)
1m-17.29%
3m-20.79%
6m-32.16%
1yr-42.83%
Volume Change (%)
10d/3m-10.59%
Price vs... (%)
52w High-49.57%
50d MA-4.07%
200d MA-22.94%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-957.1%
Return on Equity-183.58%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Oct 202431st Oct 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Sernova EPS forecast chart

Profile Summary

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

Directors

Last Annual
October 31st, 2023
Last Interim
January 31st, 2024
Incorporated
November 1st, 2001
Public Since
April 15th, 1999
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
ca flag iconToronto Stock Exchange
Shares in Issue
303,407,686

SVA Share Price Performance

Upcoming Events for SVA

Sernova Corp Annual Shareholders Meeting

Q2 2024 Sernova Corp Earnings Release

Q3 2024 Sernova Corp Earnings Release

Similar to SVA

Picture of Bausch + Lomb logo

Bausch + Lomb

ca flag iconToronto Stock Exchange

Picture of Hamilton Thorne logo

Hamilton Thorne

ca flag iconToronto Stock Exchange

Picture of Profound Medical logo

Profound Medical

ca flag iconToronto Stock Exchange

Picture of Titan Medical logo

Titan Medical

ca flag iconToronto Stock Exchange

Picture of Vitalhub logo

Vitalhub

ca flag iconToronto Stock Exchange

FAQ